(Source: Business Wire)

Invacare Corporation (NYSE:IVC) ("Invacare" or the "Company") announces
that it will release its financial results for the third quarter 2009
before the market opens on Thursday, October 22, 2009. The Company will
sponsor a conference call for investors and other interested parties on
Thursday, October 22, 2009 at 8:00 AM ET to discuss the Company's
performance.
Those wishing to participate in the live call should dial
1-888-498-8379, or +1-706-679-5239 for international callers, and enter
meeting ID 33374310.
A digital recording will be available two hours after completion of the
conference call, from October 22, 2009 to October 29, 2009. To access
the recording, US/Canada callers should dial 1-800-642-1687 or
+1-706-645-9291 for international callers, and enter the Conference ID
33374310.
Invacare Corporation (NYSE:IVC), headquartered in Elyria, Ohio, is the
global leader in the manufacture and distribution of innovative home and
long-term care medical products that promote recovery and active
lifestyles. The Company has 6,000 associates and markets its products in
80 countries around the world. The Company was named to the 2009 Fortune
1000 list (ranking 983) and to the 2009 IndustryWeek U.S. Manufacturing
500 (ranking 393). For more information about the Company and its
products, visit Invacare's website at www.invacare.com.
This press release contains forward-looking statements within the
meaning of the "SafeHarbor" provisions of the Private Securities
Litigation Reform Act of 1995. Terms such as "will," "should," "plan,"
"intend," "expect," "continue," "forecast," "believe," "anticipate" and
"seek," as well as similar comments, are forward-looking in nature.
Actual results and events may differ significantly from those expressed
or anticipated as a result of risks and uncertainties which include, but
are not limited to, the following: possible adverse effects of being
substantially leveraged, which could impact our ability to raise
capital, limit our ability to react to changes in the economy or our
industry or expose us to interest rate or event of default risks;
adverse changes in government and other third-party payor reimbursement
levels and practices; consolidation of health care providers and our
competitors; loss of key health care providers; ineffective cost
reduction and restructuring efforts; inability to design, manufacture,
distribute and achieve market acceptance of new products with higher
functionality and lower costs; extensive government regulation of our
products; lower cost imports; increased freight costs; failure to comply
with regulatory requirements or receive regulatory clearance or approval
for our products or operations in the United States or abroad; potential
product recalls; uncollectible accounts receivable; the uncertain impact
on our providers, on our suppliers and on the demand for our products of
the recent global economic downturn and general volatility in the credit
and stock markets;difficulties in implementing an Enterprise Resource
Planning system; legal actions or regulatory proceedings and
governmental investigations; product liability claims; inadequate
patents or other intellectual property protection; incorrect assumptions
concerning demographic trends that impact the market for our products;
provisions of Ohio law or in our debt agreements, our shareholder rights
plan or our charter documents that may prevent or delay a change in
control; the loss of the services of our key management and personnel;
decreased availability or increased costs of raw materials which could
increase our costs of producing our products; inability to acquire
strategic acquisition candidates because of limited financing
alternatives; risks inherent in managing and operating businesses in
many different foreign jurisdictions; increased security concerns and
potential business interruption risks associated with political and/or
social unrest in foreign countries where the company's facilities or
assets are located; exchange rate and tax rate fluctuations, as well as
the risks described from time to time in Invacare's reports as filed
with the Securities and Exchange Commission. Except to the extent
required by law, we do not undertake and specifically decline any
obligation to review or update any forward-looking statements or to
publicly announce the results of any revisions to any of such statements
to reflect future events or developments or otherwise.
A service of YellowBrix, Inc.